CAS: 1206102-07-9; Methyl 3-(Benzyloxy)-1-(2,3-Dihydroxypropyl)-4-Oxo-1,4-Dihydropyridine-2-Carboxylate

该化合物是一种含有二丙烯核心功能的丙烯衍生物,以苯氧基和二羟丙基丙基替代成分为主,其结构在2位置上包含一个碳oxy酸组,增强了其进一步化学改造的潜力.多个氢氧基组的存在改善了极地溶剂的溶性,使之适合水相反应.这一化合物对医药化学具有兴趣,因为它具有作为生物活性分子的手杖的潜力,特别是在研制酶抑制剂或金属切合剂方面,在生理条件下的稳定性和与核素或电极的再活动在合成应用中的效用进一步扩大.

英文名称Methyl 3-(Benzyloxy)-1-(2,3-Dihydroxypropyl)-4-Oxo-1,4-Dihydropyridine-2-Carboxylate
中文名称度鲁特韦中间体-6
IUPAC名称methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate
其它别名Methyl 3-(Benzyloxy)-1-(2,3-Dihydroxypropyl)-4-Oxo-1,4-Dihydropyridine-2-Carboxylate; 3-Benzyloxy-1-(2,3-Dihydroxy-Propyl)-4-Oxo-1,4-Dihydro-Pyridine-2-Carboxylic Acid Methyl Ester; 2-Pyridinecarboxylic Acid, 1-(2,3-Dihydroxypropyl)-1,4-Dihydro-4-Oxo-3-(Phenylmethoxy)-, Methyl Ester; 1-(2,3-Dihydroxypropyl)-4-Oxo-3-[(Phenylmethyl)Oxy]-1,4-Dihydro-2-Pyridinecarboxylic Acid Methyl Ester
CAS编号1206102-07-9
MFCD编号:MFCD22741605
分子式:C17H19NO6
分子量:333.34
产品CID: 274954
产品分类医药中间体 → 原料药中间体

相似结构搜索
InChIKey: JUVSRACZYLMJQD-UHFFFAOYNA-N
InChI=1S/C17H19NO6/c1-23-17(22)15-16(24-11-12-5-3-2-4-6-12)14(21)7-8-18(15)9-13(20)10-19/h2-8,13,19-20H,9-11H2,1H3…
计算化学: 氢键受体数7.0氢键供体数2.0可旋转键数8.0

MSDS等安全信息

警示词Warning
危险描述H302-H315-H319-H335-
防范说明P261-P305+P351+P338-
安全声明H303+H313+H333

上下游产品

1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid methyl iodide dimethyl sulfate 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylic acid ethyl estermethyl 1-(2,2-dihydroxyethyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate 5-bromo-1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid methyl ester

合成工艺路线路线简述

麦芽醇置于ruthenium Trichloride,Sodium Hypochlorite,Sodium Periodate,2,2,6,6-四甲基哌啶氧化物,硫酸,碳酸氢钠,Potassium Carbonate,甲基磺酰氯,三乙胺,Lithium Hexamethyldisilazane体系中,用四氢呋喃,N-甲基吡咯烷酮,乙醇,水,乙酸乙酯,乙腈用作溶剂,化学反应 13.0H,反应生成度鲁特韦中间体-6
参考文献:实用且可扩展的合成方法制备多洛格韦钠:大规模合成路线的改进
标题:实用且可扩展的合成方法制备多洛格韦钠:大规模合成路线的改进
摘要:从容易获得的原料麦芽酚(2)开始,建立了一种实用且可扩展的合成方法以获得dolutegravir钠(1).该合成方法包括麦芽酚和钯催化的酰胺化的可扩展氧化过程,用于引入酰胺部分,从而导致在短合成步骤中的实际制造方法.本文所述的合成方法使得能够进行多千克规模的高纯度1的制造.
Doi:10.1021/acs.Oprd.8B00409

海关参考信息

2902300000-甲苯
2905122000-异丙醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-9365587-B2
优先权日:2008-12-11
标题:Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
发明人：YOSHIDA HIROSHI; TAODA YOSHIYUKI; JOHNS BRIAN ALVIN; KAWASUJI TAKASHI; NAGAMATSU DAIKI
权利人:SHIONOGI & CO; VIIV HEALTHCARE CO
摘要:The invention is a process for the preparation of a compound of the following formula (I): n nwherein R is â€”CHO, â€”CH(OH) 2 or â€”CH(OH)(OR 4 ); P 1 is H or a hydroxyl protecting group; P 3 is H or a carboxy protecting group; R 3 is H, halogen, hydroxy, optionally substituted lower alkyl, optionally substituted cycloalkyl, etc.; R x is H, halogen or R 2 â€”Xâ€”NR 1 â€”C(O)â€”; etc. as defined in the specification. The compounds are useful as intermediates in synthesizing compounds having HIV integrase inhibitory activity.

专利号:US-8754214-B2
优先权日:2008-12-11
标题 :Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates

专利号:US-2014094605-A1
优先权日:2008-12-11
标题 :Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates

专利号:JP-6130891-B2
优先权日:2008-12-11
标题 :Synthesis of carbamoylpyridone HIV integrase inhibitors and their intermediates

专利号:US-8624023-B2
优先权日:2008-12-11
标题:Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates

专利号:SG-171308-A1
优先权日:2008-12-11
标题:Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates